Follow
Christine M. Lovly, MD, PhD
Christine M. Lovly, MD, PhD
Associate Professor of Medicine, Vanderbilt University Medical Center
Verified email at vumc.org
Title
Cited by
Cited by
Year
ROS1 rearrangements define a unique molecular class of lung cancers
K Bergethon, AT Shaw, SHI Ou, R Katayama, CM Lovly, NT McDonald, ...
Journal of clinical oncology 30 (8), 863, 2012
19332012
Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology
DS Ettinger, DE Wood, DL Aisner, W Akerley, J Bauman, LR Chirieac, ...
Journal of the National Comprehensive Cancer Network 15 (4), 504-535, 2017
11782017
Mechanisms of receptor tyrosine kinase activation in cancer
Z Du, CM Lovly
Molecular cancer 17, 1-13, 2018
8202018
NCCN guidelines insights: non–small cell lung cancer, version 2.2021: featured updates to the NCCN guidelines
DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ...
Journal of the National Comprehensive Cancer Network 19 (3), 254-266, 2021
7722021
Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology
DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ...
Journal of the National Comprehensive Cancer Network 20 (5), 497-530, 2022
6662022
NCCN guidelines insights: non–small cell lung cancer, version 1.2020: featured updates to the NCCN guidelines
DS Ettinger, DE Wood, C Aggarwal, DL Aisner, W Akerley, JR Bauman, ...
Journal of the National Comprehensive Cancer Network 17 (12), 1464-1472, 2019
6612019
Mechanisms of acquired resistance to first-and second-generation EGFR tyrosine kinase inhibitors
D Westover, J Zugazagoitia, BC Cho, CM Lovly, L Paz-Ares
Annals of oncology 29, i10-i19, 2018
5602018
First-line nivolumab plus ipilimumab in advanced non–small-cell lung cancer (CheckMate 568): outcomes by programmed death ligand 1 and tumor mutational burden as biomarkers
N Ready, MD Hellmann, MM Awad, GA Otterson, M Gutierrez, JF Gainor, ...
Journal of Clinical Oncology 37 (12), 992, 2019
5312019
Acquired Resistance to KRASG12C Inhibition in Cancer
MM Awad, S Liu, II Rybkin, KC Arbour, J Dilly, VW Zhu, ML Johnson, ...
New England Journal of Medicine 384 (25), 2382-2393, 2021
5292021
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
DB Johnson, MV Estrada, R Salgado, V Sanchez, DB Doxie, SR Opalenik, ...
Nature communications 7 (1), 10582, 2016
5032016
NCCN guidelines insights: non–small cell lung cancer, version 5.2018
DS Ettinger, DL Aisner, DE Wood, W Akerley, J Bauman, JY Chang, ...
Journal of the National Comprehensive Cancer Network 16 (7), 807-821, 2018
5012018
Non–small cell lung cancer, version 2.2013
DS Ettinger, W Akerley, H Borghaei, AC Chang, RT Cheney, LR Chirieac, ...
Journal of the National Comprehensive Cancer Network 11 (6), 645-653, 2013
4942013
Targeted next generation sequencing identifies markers of response to PD-1 blockade
DB Johnson, GM Frampton, MJ Rioth, E Yusko, Y Xu, X Guo, RC Ennis, ...
Cancer immunology research 4 (11), 959-967, 2016
4672016
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
EE Vokes, N Ready, E Felip, L Horn, MA Burgio, SJ Antonia, OA Frontera, ...
Annals of oncology 29 (4), 959-965, 2018
4552018
NCCN guidelines insights: non–small cell lung cancer, version 4.2016
DS Ettinger, DE Wood, W Akerley, LA Bazhenova, H Borghaei, ...
Journal of the National Comprehensive Cancer Network 14 (3), 255-264, 2016
4542016
Non–small cell lung cancer
DS Ettinger, W Akerley, H Borghaei, AC Chang, RT Cheney, LR Chirieac, ...
Journal of the National Comprehensive Cancer Network 10 (10), 1236-1271, 2012
4252012
Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor–Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations
YY Janjigian, EF Smit, HJM Groen, L Horn, S Gettinger, DR Camidge, ...
Cancer discovery 4 (9), 1036-1045, 2014
4242014
Burnout and career satisfaction among US oncologists
TD Shanafelt, WJ Gradishar, M Kosty, D Satele, H Chew, L Horn, B Clark, ...
Journal of Clinical Oncology 32 (7), 678, 2014
4172014
Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung …
YK Chae, A Arya, W Iams, MR Cruz, S Chandra, J Choi, F Giles
Journal for immunotherapy of cancer 6, 1-27, 2018
4062018
MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries
M Bar, SK Wyman, BR Fritz, J Qi, KS Garg, RK Parkin, EM Kroh, ...
Stem cells 26 (10), 2496-2505, 2008
4042008
The system can't perform the operation now. Try again later.
Articles 1–20